Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.

Conclusions: Our results suggest that osteopontin may be a potential therapeutic target for patients with ESCC treated with preoperative chemoradiotherapy. PMID: 29854808 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29854808?dopt=Abstract

Source: Biomed Res - June 3, 2018 Category: Research Authors: Chiu TJ, Lu HI, Chen CH, Huang WT, Wang YM, Lin WC, Li SH Tags: Biomed Res Int Source Type: research